Lasa Supergenerics Ltd

Company Profile

Lasa Supergenerics Ltd had its IPO on under the ticker symbol LASA.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Lasa Supergenerics Ltd has a staff strength of 0 employees.

Stock update

Shares of Lasa Supergenerics Ltd opened at ₹28.7 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹27.86 - ₹28.85, and closed at ₹27.87.

This is a -4.95% slip from the previous day's closing price.

A total volume of 27,823 shares were traded at the close of the day’s session.

In the last one week, shares of Lasa Supergenerics Ltd have slipped by -9.75%.

Lasa Supergenerics Ltd's Key Ratios

Lasa Supergenerics Ltd has a market cap of ₹880.97 million, indicating a price to book ratio of 1.0658 and a price to sales ratio of 1.0688.

In the last 12-months Lasa Supergenerics Ltd’s revenue was ₹1.30 billion with a gross profit of ₹449.37 million and an EBITDA of ₹-65936000. The EBITDA ratio measures Lasa Supergenerics Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Lasa Supergenerics Ltd’s operating margin was -15.45% while its return on assets stood at -6.89% with a return of equity of -28.94%.

In Q1, Lasa Supergenerics Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a negative 31%.

Lasa Supergenerics Ltd’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹-7.71 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Lasa Supergenerics Ltd’s profitability.

Lasa Supergenerics Ltd stock is trading at a EV to sales ratio of 1.0445 and a EV to EBITDA ratio of 47.0096. Its price to sales ratio in the trailing 12-months stood at 1.0688.

Lasa Supergenerics Ltd stock pays annual dividends of ₹0 per share, indicating a yield of 1.15% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹1.64 billion

Total Liabilities

₹427.28 million

Operating Cash Flow

₹111.95 million

Capital Expenditure

₹0

Dividend Payout Ratio

0%

Lasa Supergenerics Ltd ended 2024 with ₹1.64 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.64 billion while shareholder equity stood at ₹1.18 billion.

Lasa Supergenerics Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹427.28 million in other current liabilities, 501012000.00 in common stock, ₹681.85 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹8.00 million and cash and short-term investments were ₹23.90 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.00.

Lasa Supergenerics Ltd’s total current assets stands at ₹392.21 million while long-term investments were ₹0 and short-term investments were ₹15.91 million. Its net receivables were ₹24.78 million compared to accounts payable of ₹94.27 million and inventory worth ₹139.03 million.

In 2024, Lasa Supergenerics Ltd's operating cash flow was ₹111.95 million while its capital expenditure stood at ₹0.

Comparatively, Lasa Supergenerics Ltd paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹27.87

52-Week High

₹43.7169

52-Week Low

₹17.25

Analyst Target Price

₹

Lasa Supergenerics Ltd stock is currently trading at ₹27.87 per share. It touched a 52-week high of ₹43.7169 and a 52-week low of ₹43.7169. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹25.11 and 200-day moving average was ₹25.8 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 6422.3% of the company’s stock are held by insiders while 0% are held by institutions.